Technologies][ZBRA]• Vol: 1,195,593-$24.099.43%$231.32[KKR][KKR]• Vol: 15,344,019-$8.998.89%$92.19 Hims & Hers Snaps EPS Losing Streak but Shares Still in Free Fall - 24/7 Wall St.[S&P 5006,852.00 +0.06%] [Dow Jones48,925.20 +0.15%][Nasdaq 10024,773.40 +0.12%][Russell 20002,626.72 -0.07%][FTSE 10010,679.60 -0.04%][Nikkei 22557,615.30 +1.43%][Investing]# Hims & Hers Snaps EPS Losing Streak but Shares Still in Free Fall### Quick ReadHims & Hers (HIMS) beat Q4 EPS by 60% and delivered $2.35B full year revenue, ...

Group 1: FedEx and IEEPA Tariffs - FedEx has filed a lawsuit against the Trump administration seeking a full refund of tariffs paid under the International Emergency Economic Powers Act (IEEPA) following a Supreme Court ruling against the administration [3] - The lawsuit does not specify the amount due and names the Customs and Border Protection agency and its commissioner as defendants [3] - Other companies, including Costco, have also filed similar lawsuits, with economists projecting that reversing the IEEPA tariffs could generate up to $175 billion in refunds [4] Group 2: Hims & Hers Health - Hims & Hers Health disclosed an SEC investigation regarding its public statements and disclosures about compounded semaglutide, stating it is cooperating but cannot predict the financial impact [5][6] - The company reported Q4 GAAP EPS of $0.08, beating estimates by $0.03, with revenue rising 28.4% year-over-year to $617.8 million, in line with expectations [6] - Subscriber growth reached over 2.5 million, a 13% increase year-over-year, but the company guided for Q1 2026 revenue between $600 million and $625 million, below the consensus estimate of $652.6 million [6] Group 3: IBM and AI Claims - IBM's shares experienced their worst decline in over 25 years after AI startup Anthropic claimed its tool could modernize COBOL, a programming language used on IBM systems [7][8] - The stock fell over 13%, marking its largest single-day percentage loss since October 2000, and has dropped 27% in February, on track for its biggest monthly decline since at least 1968 [8]

Company Performance - Hims & Hers Health, Inc. (HIMS) reported a 4Q25 GAAP earnings per share of $0.08, exceeding expectations by approximately $0.03 [1] - Revenue for the quarter was $617.82 million, which was essentially in line with forecasts [1] Analyst Background - The analyst has a Master's degree in Cell Biology and extensive experience in drug discovery, focusing on biotechnology companies that innovate through unique mechanisms and therapies [1] - The analyst combines scientific expertise with financial analysis to deliver technically sound and investment-driven research [1] Investment Focus - The focus is on evaluating the science behind drug candidates, the competitive landscape, clinical trial design, and potential market opportunities while balancing financial fundamentals [1] - The goal is to provide insights that help investors understand both opportunities and risks in the biotech sector, which can yield significant returns but requires careful scrutiny [1]

U.S. rate futures have priced in a 95.9% probability of no rate change and a 4.1% chance of a 25 basis point rate cut at the March FOMC meeting.Fed Governor Christopher Waller said on Monday that his decision on whether to back an interest rate cut at the central bank’s March meeting will depend on upcoming labor-market data. “If these data support the idea of an improvement in the labor market in January that continued in February, along with additional progress toward 2% inflation, that could result in my ...

Hims & Hers Stock Drops. Why Earnings Are Underwhelming Investors. - Barron'sSkip to Main ContentThis copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.# Hims & Hers Stock Drops. Why Earnings Are Underwhelming Investors.By [Mackenzie Tatananni]ShareResize---ReprintsIn this artic ...

分组1 - Hims & Hers Health, Inc. reported quarterly earnings of $0.07 per share, exceeding the Zacks Consensus Estimate of $0.02 per share, but down from $0.11 per share a year ago, resulting in an earnings surprise of +227.10% [1] - The company posted revenues of $617.82 million for the quarter ended December 2025, which was 0.22% below the Zacks Consensus Estimate, compared to $481.14 million in the same quarter last year [2] - Hims & Hers Health shares have declined approximately 51.9% year-to-date, contrasting with the S&P 500's gain of 0.9% [3] 分组2 - The current consensus EPS estimate for the upcoming quarter is $0.13 on revenues of $645.27 million, and for the current fiscal year, it is $0.55 on revenues of $2.73 billion [7] - The Medical Info Systems industry, to which Hims & Hers Health belongs, is currently ranked in the bottom 45% of over 250 Zacks industries, indicating potential underperformance compared to higher-ranked industries [8]

Major U.S. indices traded higher Monday, with Dow Jones Futures edging up 0.09% to 48,893, the S&P 500 advancing 0.12% to 6,860.50 and the Nasdaq climbing 0.18% to 24,808.25.These are the top stocks that gained the attention of retail traders and investors through the day.Hims & Hers Health Inc. (NYSE:HIMS)Hims & Hers Health shares fell 0.77% to close at $15.51, with an intraday high of $15.80 and a low of $15.16. The stock’s 52-week range is $15.16 to $70.43. In the after-hours trading, the stock fell 8.45 ...

Core Viewpoint - Hims & Hers' expansion plans and significant spending on a Super Bowl advertisement have raised concerns among investors regarding the company's profitability, leading to a decline in stock price after the release of its quarterly results [1] Earnings Results - Hims & Hers reported a first-quarter profit forecast that fell short of market expectations, primarily due to expenditures on advertising and investments in new technology and products [1] - Following the earnings announcement, Hims & Hers' stock experienced a decline of up to 8.8% in after-hours trading, after closing down 0.8% during regular trading hours [1]

Market Overview - The U.S. markets experienced a mixed day, with a focus on the U.S. 2-year yield rising by four basis points following a Supreme Court ruling that raised questions about inflation and interest rates [2][6] - Gold prices increased as investors reacted to the risk-off sentiment in the market, while tech stocks, particularly in the software sector, saw declines of approximately 1.5% [2][4] Technology Sector - The software sector is facing significant pressure, with fears that AI tools may replace traditional software suites, leading to a 30% decline in an index of stocks including Salesforce and Adobe since their record highs [4][70] - Companies like IBM have seen substantial stock declines, with IBM down over 13% amid concerns about AI disruption [70][77] Payment and Delivery Services - PayPal's stock rose nearly 5% due to takeover interest, contrasting with the broader tech sector's struggles [3] - Delivery service companies such as DoorDash and Uber are facing challenges as hypothetical scenarios suggest that AI could disrupt their business models, contributing to stock declines [5][71] Tariff and Trade Implications - The Supreme Court ruling on tariffs has created uncertainty, particularly for major importers like Home Depot and TJX, as the market grapples with the implications of potential tariff changes [6][80] - The Attorney General of Nevada indicated that states are considering actions to recover tariffs collected, which could amount to hundreds of billions of dollars [22][23] Economic Indicators - The current economic environment shows signs of growth, with global growth rates around 2.5% and 3% including emerging markets, while inflation is gradually decreasing [10][17] - The bond market is experiencing a steepening yield curve, driven by long-term inflationary concerns and an excess supply of government debt [12][14] Trucking and Transportation Sector - The trucking industry is witnessing structural changes, with a significant reduction in driver availability leading to higher rates and potential long-term impacts on capacity [57][68] - Demand for transportation services is still down year-over-year, but there are positive indicators such as increased trade volumes and a projected recovery in the second half of the year [59][63]

Hims & Hers Health (NYSE:HIMS) Q4 2025 Earnings call February 23, 2026 05:00 PM ET Company ParticipantsAndrew Dudum - Co-founder and CEOBill Newby - Head of Investor RelationsEric Percher - Partner of Pharma Supply Chain and Digital HealthGlen Santangelo - Managing DirectorMaria Ripps - Managing Director of Equity ResearchMark Mahaney - Senior Managing Director and Head of Internet ResearchYemi Okupe - CFOConference Call ParticipantsBrian Tanquilut - Senior Analyst of Healthcare Services and Digital Health ...